2937.11.00.00/Somatrogon (Long-Acting Growth Hormone)/Canada

Somatrogon (Long-Acting Growth Hormone) from Canada

Somatrogon is a long-acting structural analogue of somatotropin created by linking human growth hormone to a CTP (C-terminal peptide) sequence from hCG beta subunit. This modification extends its half-life for weekly dosing in growth hormone deficiency. Classified in HTS 2937.11.00.00 as a chain-modified polypeptide analogue used primarily as a hormone.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Submit sequence analysis confirming CTP modification for chain-modified polypeptide classification

• Maintain validated cold chain (2-8°C) with temperature monitoring records

• Avoid bulk packaging declarations that might suggest non-hormonal protein status

Somatrogon (Long-Acting Growth Hormone) from Canada — Import Duty Rate | HTS 2937.11.00.00